MTOR and Insulin resistance: Rapamycin and rapamycin analogs have been widely used as immunosuppressants for preventing transplant rejection, but the non-selective inhibition of mTOR activity reportedly impairs glucose homeostasis and increases insulin resistance [46,47,48,49].